Isaac Yang

Dr. Isaac Yang

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
IYIsaac Yang
Isaac Yang
SHSeunggu J. Han
Seunggu J. Han
GKGurvinder Kaur
Gurvinder Kaur
CCCourtney Crane
Courtney Crane
APAndrew T. Parsa
Andrew T. Parsa

1 January 2017 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
PPPanayiotis E. Pelargos
Panayiotis E. Pelargos
DNDaniel T. Nagasawa
Daniel T. Nagasawa
CLCarlito Lagman
Carlito Lagman
STStephen Tenn
Stephen Tenn
JDJoanna V. Demos
Joanna V. Demos
IYIsaac Yang
Isaac Yang

1 July 2017 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
MPMaria Punchak
Maria Punchak
LCLawrance K. Chung
Lawrance K. Chung
CLCarlito Lagman
Carlito Lagman
TBTimothy T. Bui
Timothy T. Bui
JLJorge Lazareff
Jorge Lazareff
IYIsaac Yang
Isaac Yang

1 April 2010 in Neurosurgical Focus
Verified
Journal Article
Closed access
IYIsaac Yang
Isaac Yang
MSMichael E. Sughrue
Michael E. Sughrue
MRMartin J. Rutkowski
Martin J. Rutkowski
RKRajwant Kaur
Rajwant Kaur
Michael E. IvanMichael E. Ivan
Michael E. Ivan
APAndrew T. Parsa
Andrew T. Parsa
Object: Craniopharyngiomas have a propensity to recur after resection, potentially causing death through their aggressive local behavior in their critical site of origin. Recent data suggest that subtotal resection (STR) followed by adjuvant radiotherapy (XRT) may be an appealing substitute for gross-total resection (GTR), providing similar rates of tumor control without the morbidity associated with aggressive resection. Here, the authors summarize the published literature regarding rates of tumor control with various treatment modalities for craniopharyngiomas. Methods: The authors performed a comprehensive search of the English language literature to identify studies publishing outcome data on patients undergoing surgery for craniopharyngioma. Rates of progression-free survival (PFS) and overall survival (OS) were determined through Kaplan-Meier analysis. Results: There were 442 patients who underwent tumor resection. Among these patients, GTR was achieved in 256 cases (58%), STR in 101 cases (23%), and STR+XRT in 85 cases (19%). The 2- and 5-year PFS rates for the GTR group versus the STR+XRT group were 88 versus 91%, and 67 versus 69%, respectively. The 5- and 10-year OS rates for the GTR group versus the STR+XRT group were 98 versus 99%, and 98 versus 95%, respectively. There was no significant difference in PFS (log-rank test) or OS with GTR (log-rank test). Conclusions: Given the relative rarity of craniopharyngioma, this study provides estimates of outcome for a variety of treatment combinations, as not all treatments are an option for all patients with these tumors.

1 November 2010 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
IYIsaac Yang
Isaac Yang
TTTarik Tihan
Tarik Tihan
SHSeunggu J. Han
Seunggu J. Han
MWMargaret R. Wrensch
Margaret R. Wrensch
JWJohn Wiencke
John Wiencke
APAndrew T. Parsa
Andrew T. Parsa

23 April 2015 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
JAJohnny C. Akers
Johnny C. Akers
VRValya Ramakrishnan
Valya Ramakrishnan
RKRyan Kim
Ryan Kim
SPShirley Phillips
Shirley Phillips
VKVivek Kaimal
Vivek Kaimal
CCClark C. Chen
Clark C. Chen